Navigation Links
Lab Study Finds Protein That May Inhibit Cancer Spread
Date:6/23/2009

Tests in mice show prosaposin injections reduce tumor growth

MONDAY, June 22 (HealthDay News) -- A protein produced by certain kinds of tumors inhibits the spread of cancer and could potentially be harnessed as a cancer treatment, researchers say.

Currently, there is no approved therapy for inhibiting or treating metastasis -- the migration of cancer cells from the original cancer site to other parts of the body. Metastasis is one of the leading causes of cancer death.

Researchers at Children's Hospital Boston had found previously that metastatic tumors prepare "landing places" for cancer in other organs by secreting certain proteins that encourage tumor growth and attract feeder blood vessels. In the new study, they found that non-metastatic tumors secrete a protein called prosaposin that inhibits metastasis by promoting production of factors that block the growth of blood vessels, according to a news release from the hospital.

Laboratory tests showed that high levels of prosaposin were secreted by non-metastatic, localized prostate and breast tumors but that metastatic tumors secreted very little of the protein. The researchers then added prosaposin to highly metastatic tumor cells and injected them into mice.

Lung metastases in the mice were reduced by 80 percent, lymph node metastases disappeared, and there was a significant increase in survival time, the researchers found.

When prosaposin was injected directly into mice after they'd been injected with tumors cells, there was a large reduction in lung metastases and the mice lived at least 30 percent longer than those who didn't receive prosaposin, the study reported.

Further research revealed that prosaposin stimulated activity of the tumor suppressor p53 in connective tissue (stroma) surrounding the tumor, which then stimulated production of an inhibitor of blood vessel growth in the tumor stroma and in distant cells, according t
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lab Study Finds Protein That May Inhibit Cancer Spread
(Date:3/31/2015)... 2015 On November 24, 2014, Per Wickstrom ... to discuss the problem of substance abuse and the solutions ... of drug abuse and recovery, gives a unique first-person perspective ... his teammates on the New York Giants, Taylor’s early career ... drug tests, yet he was able to straighten out long ...
(Date:3/31/2015)... Angeles, CA (PRWEB) March 31, 2015 ... references on the Internet, is proudly enduring adding news ... cosmetic doctors and the consumers of plastic surgery and ... With more user-friendly pages and interconnected sections, the Cosmetic ... The newest addition to the Cosmetic Town site navigation, ...
(Date:3/31/2015)... The American College of Traditional Chinese ... April will include interesting workshops, lectures and more. The ... a.m. April 6, ACTCM welcomes the newest cohort. The ... Pioneer Square Campus located at 555 DeHaro St. , ... 14, Students will be updated on the upcoming merger ...
(Date:3/31/2015)... Stamford, CT (PRWEB) March 31, 2015 Calling ... fight against Lyme and other tick-borne diseases! The first annual ... at Cove Island Park in Stamford, CT. The event, hosted ... Alliance (TBDA), will raise funds to support research and ... family event, open to all ages and abilities, will feature ...
(Date:3/31/2015)... Medical DNA Labs, LLC, An Affiliate of Physician ... Accreditation by COLA, a national healthcare accreditation organization. ... standards of quality in day-to-day operations, demonstrate continued accuracy ... rigorous on-site laboratory survey. Medical DNA Labs, LLC ... long-term commitment to provide quality service to its patients. ...
Breaking Medicine News(10 mins):Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:ACTCM Announces April Event Schedule 2Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2
... June 29 Air Methods Corporation (Nasdaq: AIRM ... announced today it has filed a petition with the National ... cause determination related to the June 29, 2008 mid-air collision ... states that "both pilots failed to see and avoid the ...
... Helicobacter pylori survives in the body by manipulating ... thesis from the Sahlgrenska Academy at the University of ... against the common peptic ulcer bacterium. About half ... mainly in the stomach. Most infected individuals never experience ...
... Black gay men have less choice when it comes to sexual ... are closely knit. These tightly interconnected networks make the rapid spread ... social and sexual mixing between ethnic groups in men who have ... San Francisco Department of Public Health in the US, show that ...
... new study by The Pew Charitable Trusts, Philadelphia Research Initiative reports ... money it needs to make good on its obligation to past ... underfunded since 1996, and there is little prospect that the picture ... The report, Quiet No More: Philadelphia Confronts the ...
... AMSTERDAM, June 29 , ... Hiring and,Collaboration Decisions , Elsevier, ... and services, today announced the launch of SciVal,Spotlight, a ... of research performance to evaluate, establish,and execute more informed ...
... new type of body armour made from cement. The new ... make a material tough enough to withstand most types of bullets. ... is being carried out the School of Civil Engineering at the ... said: "By using cement instead of alumina we are confident we ...
Cached Medicine News:Health News:Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination 2Health News:Black gay men may be at increased HIV risk 2Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 2Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 3Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 4Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 5Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 6Health News:Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance 2Health News:Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance 3Health News:Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance 4
(Date:3/31/2015)... Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: ... expand its planned bullous pemphigoid (BP) clinical development for ... Pemphigoid is an orphan auto-immune blistering disease of the ... Europe . As previously ... Phase II clinical trial in Israel ...
(Date:3/31/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... 150mg, 225mg and 300mg oral tablets, indicated for use ... market for Propafenone Hydrochloride 150mg, 225mg and 300mg tablets ... Arthur S. Przybyl , President and Chief ... launch of our fourth product from the portfolio of ...
(Date:3/31/2015)... 2015   Unique Pharmaceuticals , a 503B outsourcing ... the company has initiated sterile compounding operations meeting the ... a company is to meet and exceed industry standards," ... the new regulations is validation of our quality management ... of our industry, investing in its continued success and ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
... Delivery System Has Potential to, Help Solve Radiation Therapy Access and ... ... Symposium, WASHINGTON, Sept. 8 Early clinical experience with the,FDA ... non-isotopic treatment is a viable,option for adjuvant therapy for early-stage breast ...
... Compared to FISH ... - Company to Include Reporting for HER2 Gene Expression in All Oncotype DX ... Reports by End ... GHDX ) today announced results from two studies demonstrating,that quantitative reporting for ...
Cached Medicine Technology:Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 2Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 3Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5
Inquire...
... Eliminate aerosol contamination, ... reactions in PCR. Hydrophobic, ... Only air can pass ... tips, in contrast to ...
300 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 250 and 300 L pipettes....
... Resistant Tips offer a safe alternative to ... designed for applications such as PCR(a), pipetting ... ART Tips are excellent for tissue culture, ... ART Tips prevent aerosol contaminants and liquids ...
Medicine Products: